This 1-hour course uses real-world case studies to help medical professionals strengthen their clinical judgment in treating opioid use disorder, with a focus on rural communities.

Learn about the most recent developments with the new buprenorphine limit, the qualifications needed for prescribing, what a “qualified practice setting” is, and how ASAM members and other doctors may be affected by this recent development.

Watch the on-demand recording of the webinar hosted by AAAP, APA, and ASAM to learn about the transitional final regulation released and provisions included in CARES Act to further modernize and align Part 2 with the Health Insurance Portability and Accountability Act (HIPAA).

On-demand ASAM CONTINUUM course for providers.

This 4-hour workshop is designed to help counselors, social workers, administrators, and other clinical staff learn how to navigate and appropriately use the ASAM CO-Triage tool to generate a provisional level of care placement for individuals with alcohol and substance use problems.

This on-demand recording from the 2nd Annual ASAM State Advocacy Summit provides an overview of the most important issues at the state level. The Summit reviews the 2022 midterm election landscape, new resources for ASAM state chapter leaders, and other advocacy topics.

This 1-hour, journal article-based CME activity reviews a study of an educational intervention to increase HIV clinicians' naloxone prescribing. The intervention was designed to reduce overdose mortality among persons living with HIV, overdose being a major cause of preventable death in this population.

This 1-hour, journal article-based CME activity is based on a narrative review summarizing existing research on pharmaceutical fentanyl as it is used in medical settings, and considers how its findings may inform research on illicitly manufactured fentanyl (IMF) and populations using IMF.

This 1-hour, journal article-based CME activity reviewed a qualitative study of clinician beliefs and perceptions about the impacts of changes to the delivery of medication treatment for opioid use disorder (MOUD) during the COVID-19 pandemic, with a focus on the switch to care delivery via telemedicine. Perceived benefits and limitations of telemedicine as a care delivery modality for MOUD and beliefs about impacts on patient safety and well-being were explored. Implications for post-pandemic continuance of telemedicine in MOUD care were also discussed.

This one-hour, on-demand, journal article-based activity explores a qualitative study of patient perspectives and priorities regarding receiving care for OUD in primary care settings. Patients were interviewed about their experiences with primary care-based OUD treatment, particularly in comparison to their experiences with specialty clinics for MOUD care experiences. Based on these findings, ways that the primary care environment may be optimized to improve the overall health of patients with OUD were discussed.